Jennifer Fox to Present at BIO's IP & Diagnostics Symposium (BIO IPDX)
Jennifer Fox will speak at BIO's IP & Diagnostics Symposium (BIO IPDX) which will review the current patent law landscape and evaluate the impact on both the genetic diagnostics and biopharmaceutical sectors. The second annual event will take place on September 26 in Alexandria, VA.
Ms. Fox will be discussing recent IP patent litigation and disputes with a group of other bio and IP professionals. They will discuss issues such as the impact of the Supreme Court decisions in Myraid and Prometheus and their impact on the biotech industry, ongoing cases, recent decisions, and the impact these cases may have on the industry.
Click here for more information or to register.